戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                    Accuracy was assessed by analysis of SRM (Standard Reference Material)
2                                     Quantification accuracy was assessed with Dice scores, group comparisons and correlat
3                                  Striatal dopamine activity was assessed as K(i)(cer) value using [(18)F]DOPA PET before
4 he gradual alteration of mortality risk after ICU admission was assessed using left-truncation with increasing minimum su
5 w vs. intermediate-to-high AD neuropathologic change (ADNC) was assessed for all biomarkers.
6 sess which memories predicted drinking, real-world behavior was assessed in patients with AUD at baseline and for 4 weeks
7 ied CpGs, association of DNAm with gene expression in blood was assessed.
8             The effect of several variables on MBLs changes was assessed via univariate and multivariate generalized esti
9  of the amygdala, fornix, uncinate fasciculus, and cingulum was assessed using fractional anisotropy and mean diffusivity
10                                                  The cohort was assessed for subsequent future fragility fractures.
11                     Finally, the stability of the composite was assessed by means of recyclability tests.
12                                   The breast tissue density was assessed using ACR BI-RADS.
13 rsion 5, and its relationship with parenchyma-absorbed dose was assessed using linear models.
14                                      Impact of additive EBL was assessed using 20 3-factor fistula risk score (FRS) scena
15 econd dose, the primary endpoint (overall vaccine efficacy) was assessed in the first 11 months, and the secondary endpoi
16                                        The primary endpoint was assessed in the intention-to-treat analysis set, after al
17                                                  Expression was assessed using the Illumina HT12 array and analysed in R
18                                             Aerobic fitness was assessed by the time for a 3-kilometer run test, and anae
19                                        Hippocampal function was assessed using a verbal memory task.
20                                             Kidney function was assessed by measurement of glomerular filtration rate (GF
21 nternational Prostate Symptom Score (IPSS); sexual function was assessed by 5-item version of the International Index of
22                                            Urinary function was assessed by residual urine volume, maximal flow rate (MFR
23 al echocardiographic measures in the absence of clinical HF was assessed.
24                                          Dementia incidence was assessed over 3-5 years, with diagnosis according to the
25                      Neural activity after serum incubation was assessed in mouse slices using molecular markers and elec
26 mittee on Cancer (AJCC) tumor stage at each criterion level was assessed by using Cohen kappa statistics.
27  of regional genes and a retinal enhancer RNA at this locus was assessed by qPCR.
28                                                   Mediation was assessed using structural equation modeling.
29                                Oral inflammatory load (OIL) was assessed in a salivary rinse sample using fluorescence mi
30                                                        Pain was assessed by von Frey assay and dorsal root ganglia (DRG)
31 d RBC-MVs to activate each zymogen of the intrinsic pathway was assessed in a buffer system.
32                    Based on the RCSQ results, sleep quality was assessed to be better in the melatonin group than that in
33 nducing cardiomyopathy, and cardiac function and remodeling was assessed by echocardiography 10 weeks after surgery.
34                                                    Response was assessed in all patients who met the eligibility criteria
35                                                      Safety was assessed in all participants who received at least one do
36                                                      Safety was assessed in all patients who received at least one dose o
37                                                      Safety was assessed up to 48 h post-injection.
38 een May 19 and October 27, 2016, a systematic random sample was assessed for eligibility (HIV+, age >= 14 years, on ART >
39 roducibility of PET measurements from test and retest scans was assessed.
40 ive accuracy of a previously validated polygenic risk score was assessed among 4847 adults of white European ancestry, ag
41 nd cross-reactivity with allergens of other poultry species was assessed in inhibition immunoblots.
42                                           Surface stability was assessed using infectivity, SARS-CoV-2 survived on stainl
43 lipid peroxidation) on mitochondrial function and structure was assessed in HL1 murine cardiomyocytes and human induced p
44 -inferiority of DTG + FTC versus cART for viral suppression was assessed using a stratified Mantel-Haenszel risk differen
45                                     Post-operative survival was assessed using time-dependent Cox proportional hazard reg
46 ty, LV assist device implantation, or heart transplantation was assessed.
47                                    Impact on carbapenem use was assessed at several cut-off points.
48 which has been linked to nonosmotic release of vasopressin) was assessed.
49 ne of these deaths was due to gastric adenocarcinoma, which was assessed by the investigator as related to ruxolitinib tr
50 lationship between mean and sectoral variation of ACA width was assessed using locally-weighted scatterplot smoothing (LO